David Callanan MD

PubMed

• 8 citations
  PolySialic Acid Nanoparticles Actuate Complement-Factor-H-Mediated Inhibition of the Alternative Complement Pathway: A Safer Potential Therapy for Age-Related Macular ...
  Sheri L Peterson, Anitha Krishnan, Diyan Patel, Ali Khanehzar, Amit Lad
  Pharmaceuticals. 2024-04-17
• 6 citations
  Comprehensive Ocular and Systemic Safety Evaluation of Polysialic Acid-Decorated Immune Modulating Therapeutic Nanoparticles (PolySia-NPs) to Support Entry into First-...
  Anitha Krishnan, David G Callanan, Victor G Sendra, Amit Lad, Sunny Christian
  Pharmaceuticals. 2024-04-09
• 9 citations
  Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results.
  David Callanan, Rahul N Khurana, Raj K Maturi, Sunil Patel, Charles C Wykoff
  Clinical Ophthalmology. 2023-01-01

Journal Articles

• Use of Corticosteroids in the Treatment of Patients With Diabetic Macular Edema Who Have a Suboptimal Response to Anti-VEGF: Recommendations of an Expert Panel  
  Regillo CD, Callanan DG, Fine HF, Do DV, Holekamp NM, Kuppermann BD, Singer MA, Singh RP, Ophthalmic Surg Lasers Imaging Retina, 1/1/2017
• A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema  
  Callanan DG, Loewenstein A, Patel SS, Massin P, Corcostegui B, Li XY, Jiao J, Hashad Y, Whitcup SM, Graefes Arch Clin Exp Ophthalmol, 1/1/2017
• Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) Study  
  Sepah YJ, Sadiq MA, Boyer D, Callanan D, Gallemore R, Bennett M, Marcus D, Halperin L, Hassan M, Campochiaro PA, Nguyen QD, Do D, Ophthalmology, 1/1/2016

Books/Book Chapters

• Surgical Management of Inflammatory Eye Disease 
  Chapter: Intraocular Corticosteroid Implants. 
  Callanan DEditors: Becker and David.Springer-Verlag2008
• Albert and Jakobiec's Principles and Practice of Ophthalmology 
  Chapter: Retinal Toxicity of Systemic Medication. 
  Williams P and Callanan DElsevierEdition 3rd,2008
• Clinical Retina 
  Chapter: Drug toxicities. 
  Callanan DGEditors: Quillen and Blodi.AMA Press, Chicago2002

Abstracts/Posters

• "Combination Therapy for Exudative Age Related Macular Degeneration"
  Callanan DG, XXVIth Meeting of the Club Jules Gonin, St. Moritz, Switzerland, 1/12/2008
• Fluocinolone Acetonide Intravitreal Implant for the Treatment of Uveitis Affecting the Posterior Segment: 34 Week Results of a Randomized, Masked, Multi-center Clinica...
  Fluocinolone Acetonide Uveitis Study Group, American Uveitis Society, Vail, CO, 1/19/2004

Lectures

• "The OZAB Study: A 6 Month, Prospective, Randomized Study of the Effects of Dexamethasone Intravitreal Implant with Bevacizumab Compared to Bevacizumab Alone for Centr... 
  Jersey, The Channel Islands - 1/13/2018
• "Implantation of Drug Delivery Devices" 
  Guangzhou, China - 1/13/2017
• "Abicipar Pegol (Anti-Vegf Darpin) Phase 2, Doublemasked, Randomized Study In Treatment-Na�ve Patients With Neovascular Age-Related Macular Degeneration" 
  Bordeaux, France - 1/7/2016

Other

• Guidelines for Interpreting Retinal Photographs and Coding Findings in the Submacular Surgery trials: SSt report NO. 8. 
  Submacular Surgery Trials Research Group
• Histo-pathological and Ultrastructural Features of Surgically-excised Subfoveal Choroidal Neovascular Lesions: SST Report NO. 7. 
  Submacular Surgery Trials Research Group